Advanced Search

Sensorineural Hearing Loss Stocks List

Symbol Grade Name % Change
EARS D Auris Medical Holding AG -7.69
FREQ C Frequency Therapeutics, Inc. -5.36
AKUS D Akouos, Inc. 7.53
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Hearing Hearing Loss Perception Audiology Auditory System Deafness Inner Ear Occupational Safety And Health Biology Biopharmaceutical Biotechnology Clinical Development Degenerative Disease Degenerative Diseases Disease Drug Delivery Drug Delivery Devices Dysfunction Hair Cell Multiple Sclerosis

Related ETFs - A few ETFs which own one or more of the above listed Sensorineural Hearing Loss stocks.

Symbol Grade Name Weight
BBC C Virtus LifeSci Biotech Clinical Trials ETF 0.73
SBIO C ALPS Medical Breakthroughs ETF 0.54
IWC B iShares Microcap ETF 0.28
IBB C iShares Nasdaq Biotechnology Index Fund 0.19
XBI D SPDR Series Trust SPDR S&P Biotech ETF 0.16
View all Sensorineural Hearing Loss related ETFs...
Compare ETFs
  • Compare BBC to IBB
  • Compare BBC to XBI
  • Compare SBIO to XBI

    • Recent Signals

    Date Stock Signal Type
    2021-02-25 AKUS Pocket Pivot Bullish Swing Setup
    2021-02-25 AKUS 50 DMA Support Bullish
    2021-02-25 AKUS Volume Surge Other
    2021-02-25 AKUS Wide Range Bar Range Expansion
    2021-02-25 AKUS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-02-25 AKUS Expansion Pivot Buy Setup Bullish Swing Setup
    2021-02-25 AKUS 20 DMA Support Bullish
    2021-02-25 EARS Stochastic Reached Oversold Weakness
    2021-02-25 EARS 1,2,3 Pullback Bullish Bullish Swing Setup
    2021-02-25 EARS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-02-25 EARS Fell Below 20 DMA Bearish
    2021-02-25 FREQ Fell Below 20 DMA Bearish

    Recent News for Sensorineural Hearing Loss Stocks

    Date Stock Title
    Feb 23 FREQ The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
    Feb 23 FREQ Frequency Therapeutics' FX-322 Data Published In Peer-Reviewed Journal
    Feb 23 FREQ Frequency Therapeutics' FX-322 shows positive effect in hearing loss
    Feb 22 FREQ Frequency Therapeutics Announces Publication of Phase 1/2 Data Showing Hearing Improvements in Acquired Sensorineural Hearing Loss Patients Receiving FX-322
    Related Industries: Biotechnology
    Related Stock Lists: Hearing Hearing Loss Perception Audiology Auditory System Deafness Inner Ear Occupational Safety And Health Biology Biopharmaceutical Biotechnology Clinical Development Degenerative Disease Degenerative Diseases Disease Drug Delivery Drug Delivery Devices Dysfunction Hair Cell Multiple Sclerosis

    Browse All Tags